National Asset Management, Inc. Novavax Inc Transaction History

National Asset Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$69.73 - $142.9 $146,711 - $300,661	-2,104 Closed	0 $0
Q4 2021 Jan 28, 2022	BUY	$134.56 - $217.97 $12,783 - $20,707	95 Added 4.73%	2,104 $302,000
Q3 2021 Nov 16, 2021	SELL	$177.8 - $270.58 $785,698 - $1.2 Million	-4,419 Reduced 68.75%	2,009 $420,000
Q2 2021 Aug 10, 2021	SELL	$121.0 - $257.67 $84,579 - $180,111	-699 Reduced 9.81%	6,428 $1.35 Million
Q1 2021 May 13, 2021	BUY	$112.98 - $319.93 $56,828 - $160,924	503 Added 7.59%	7,127 $1.26 Million
Q4 2020 Feb 04, 2021	BUY	$78.74 - $139.5 $66,929 - $118,575	850 Added 14.72%	6,624 $739,000
Q3 2020 Nov 09, 2020	SELL	$79.44 - $178.51 $78,645 - $176,724	-990 Reduced 14.64%	5,774 $606,000
Q2 2020 Jul 31, 2020	BUY	$13.86 - $83.61 $93,749 - $565,538	6,764 New	6,764 $564,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on National Asset Management, Inc. with notifications on news.